Showing results (1241-1250 of 1,478) with videos related to

Sort By:
Pageof 148
The Journal of Antimicrobial Chemotherapy|August 20, 2019
Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycinAbdoulie Bojang, Sarah L Baines, Liam Donovan, et al.
Applied and Environmental Microbiology|March 7, 2006
Genome sequence of the chemolithoautotrophic nitrite-oxidizing bacterium Nitrobacter winogradskyi Nb-255Shawn R Starkenburg, Patrick S G Chain, Luis A Sayavedra-Soto, et al.
The Journal of Clinical Investigation|August 9, 2014
Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistanceFelicity Payne, Rita Colnaghi, Nuno Rocha, et al.
BJU International|February 3, 2015
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279)Amit Bahl, Susan Masson, Zafar Malik, et al.
Head & Neck|July 7, 2020
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancerJammbe Z Musoro, Corneel Coens, Susanne Singer, et al.
Scientific Reports|June 27, 2024
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesotheliomaCharles S Cleeland, Karen N Keating, Brian Cuffel, et al.
The British Journal of Surgery|September 30, 2025
Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trialJack A Helliwell, Caroline H Chilton, Caroline Young, et al.
Cancer|June 16, 2018
Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trialsDivine E Ediebah, Chantal Quinten, Corneel Coens, et al.
Cancer|June 3, 2015
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)Corneel Coens, Winette T A van der Graaf, Jean-Yves Blay, et al.
Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.
Pageof 148